A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to ...

A colorectal cancer drug from Pfizer Inc. doubled survival time compared to the standard of care for a subset of patients, ...

Even though rectal bleeding is alarming, doctors say patients are ashamed to mention it, delaying colon cancer diagnosis and ...

In the realm of colorectal cancer treatments beyond surgery and radiation, one key question gained prominence in recent years ...

And here’s the kicker: Every extra kilo (2.2 pounds) at birth over “normal” birth weight — that’s 2.5 to 4 kilograms, or 5.51 ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

The burden of early-onset colorectal cancer diagnosis it not equitable across the community oncology setting , according to ...

Scientists identified a link between colorectal cancer and a toxin in the gut. Eating more fiber may help reduce your risk.

Pfizer (PFE) stock gains as Braftovi combo shows survival benefits in a late-stage trial for metastatic colorectal cancer ...

While all the recent chatter around colon cancer is alarming, new studies are also showing promising data around the positive ...

A newly developed scoring system could enhance risk prediction and guide treatment decisions for colorectal cancer, according ...

Colorectal cancer is becoming more common among younger adults. Screening guidelines have evolved to reflect that.